We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Veeva Systems (VEEV) Rises Higher Than Market: Key Facts
Read MoreHide Full Article
In the latest trading session, Veeva Systems (VEEV - Free Report) closed at $175.79, marking a +2.1% move from the previous day. The stock's change was more than the S&P 500's daily gain of 0.77%. Elsewhere, the Dow gained 0.76%, while the tech-heavy Nasdaq added 1.05%.
The stock of provider of cloud-based software services for the life sciences industry has fallen by 23.2% in the past month, lagging the Medical sector's loss of 0.28% and the S&P 500's loss of 0.98%.
The investment community will be paying close attention to the earnings performance of Veeva Systems in its upcoming release. The company is slated to reveal its earnings on March 4, 2026. The company is expected to report EPS of $1.92, up 10.34% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $808.89 million, indicating a 12.21% increase compared to the same quarter of the previous year.
VEEV's full-year Zacks Consensus Estimates are calling for earnings of $7.93 per share and revenue of $3.17 billion. These results would represent year-over-year changes of +20.15% and +15.26%, respectively.
Investors should also take note of any recent adjustments to analyst estimates for Veeva Systems. These revisions typically reflect the latest short-term business trends, which can change frequently. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, there's been a 0.31% rise in the Zacks Consensus EPS estimate. Veeva Systems is currently sporting a Zacks Rank of #3 (Hold).
In terms of valuation, Veeva Systems is presently being traded at a Forward P/E ratio of 20.28. This signifies a discount in comparison to the average Forward P/E of 21.37 for its industry.
One should further note that VEEV currently holds a PEG ratio of 0.85. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical Info Systems was holding an average PEG ratio of 1.24 at yesterday's closing price.
The Medical Info Systems industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 147, positioning it in the bottom 40% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow VEEV in the coming trading sessions, be sure to utilize Zacks.com.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Veeva Systems (VEEV) Rises Higher Than Market: Key Facts
In the latest trading session, Veeva Systems (VEEV - Free Report) closed at $175.79, marking a +2.1% move from the previous day. The stock's change was more than the S&P 500's daily gain of 0.77%. Elsewhere, the Dow gained 0.76%, while the tech-heavy Nasdaq added 1.05%.
The stock of provider of cloud-based software services for the life sciences industry has fallen by 23.2% in the past month, lagging the Medical sector's loss of 0.28% and the S&P 500's loss of 0.98%.
The investment community will be paying close attention to the earnings performance of Veeva Systems in its upcoming release. The company is slated to reveal its earnings on March 4, 2026. The company is expected to report EPS of $1.92, up 10.34% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $808.89 million, indicating a 12.21% increase compared to the same quarter of the previous year.
VEEV's full-year Zacks Consensus Estimates are calling for earnings of $7.93 per share and revenue of $3.17 billion. These results would represent year-over-year changes of +20.15% and +15.26%, respectively.
Investors should also take note of any recent adjustments to analyst estimates for Veeva Systems. These revisions typically reflect the latest short-term business trends, which can change frequently. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, there's been a 0.31% rise in the Zacks Consensus EPS estimate. Veeva Systems is currently sporting a Zacks Rank of #3 (Hold).
In terms of valuation, Veeva Systems is presently being traded at a Forward P/E ratio of 20.28. This signifies a discount in comparison to the average Forward P/E of 21.37 for its industry.
One should further note that VEEV currently holds a PEG ratio of 0.85. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical Info Systems was holding an average PEG ratio of 1.24 at yesterday's closing price.
The Medical Info Systems industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 147, positioning it in the bottom 40% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow VEEV in the coming trading sessions, be sure to utilize Zacks.com.